FCM MM Holdings, one of Mind Medicine’s (NEO: MMED) shareholders with a 6.1% stake, has formally filed a complaint with the US Securities and Exchange Commission regarding various allegations against the company. The complaint refers to current allegations the firm faces: self-dealing, a lack of significant disclosure, false statements, and public statement fraud. The shareholders’ … Continue reading Activist Investor Calls For MindMed CEO’s Termination Due To Alleged Fraudulent Acts